3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
2.2             RESEARCH METHODOLOGY STEPS
2.2.1              SECONDARY DATA
2.2.1.1            KEY DATA FROM SECONDARY SOURCES
2.2.2              PRIMARY DATA
2.2.2.1            KEY DATA FROM PRIMARY SOURCES
2.2.3              KEY INSIGHTS FROM PRIMARY SOURCES
2.3             MARKET SIZE ESTIMATION METHODOLOGY
2.3.1              REVENUE MAPPING-BASED MARKET ESTIMATION
2.4             MARKET DATA ESTIMATION AND TRIANGULATION
2.5             ASSUMPTIONS OF THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1             3D CELL CULTURE MARKET OVERVIEW
4.2             SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2019–2024 (USD MILLION)
4.3             3D CELL CULTURE MARKET SHARE, BY END USER & REGION (2018)
4.4             3D CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
5.2.1              MARKET DRIVERS
5.2.1.1            INCREASING FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING
5.2.1.2            GROWING FOCUS ON PERSONALIZED MEDICINE

5.2.1.3            INCREASING INCIDENCE OF CHRONIC DISEASES
5.2.1.4            AVAILABILITY OF FUNDING FOR RESEARCH
5.2.2              RESTRAINTS
5.2.2.1            LACK OF INFRASTRUCTURE FOR 3D CELL-BASED RESEARCH
5.2.2.2            HIGH COST OF CELL BIOLOGY RESEARCH
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGENCE OF MICROFLUIDICS-BASED 3D CELL CULTURE
5.2.3.2            EMERGING ECONOMIES
5.2.3.3            REGENERATIVE MEDICINE—AN ALTERNATIVE TO ORGAN TRANSPLANTATION
5.2.4              CHALLENGES
5.2.4.1            LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS

6.... 3D CELL CULTURE MARKET, BY PRODUCT

6.1             INTRODUCTION
6.2             SCAFFOLD-BASED 3D CELL CULTURES
6.2.1              HYDROGELS/ECM ANALOGS
6.2.1.1            HYDROGELS/ECM ANALOGS DOMINATE THE SCAFFOLD-BASED 3D CELL CULTURES MARKET
6.2.2              SOLID SCAFFOLDS.. 48
6.2.2.1            SOLID SCAFFOLDS ARE WIDELY ADOPTED IN REGENERATIVE MEDICINE AND PRECLINICAL IN VITRO TESTING
6.2.3              MICROPATTERNED SURFACES
6.2.3.1            MICROPATTERNED SURFACES ENHANCE THE EXPRESSION OF ENZYMES LEVELS AND DRUG REACTIVITY
6.3             SCAFFOLD-FREE 3D CELL CULTURES
6.3.1              LOW ATTACHMENT PLATES
6.3.1.1            LOW ATTACHMENT PLATES ARE EXPECTED TO GROW AT THE HIGHEST RATE IN THE SCAFFOLD-FREE 3D CELL CULTURES MARKET
6.3.2              HANGING DROP PLATES
6.3.2.1            HANGING DROP PLATES ARE WIDELY USED IN STEM CELL DIFFERENTIATION AND CYTOTOXICITY RESEARCH
6.3.3              3D BIOREACTORS
6.3.3.1            3D BIOREACTORS ARE COMMONLY USED IN THE MASS PRODUCTION OF CELLS
6.3.4              3D PETRI DISHES.. 59
6.3.4.1            EUROPE WILL WITNESS THE HIGHEST GROWTH IN THE 3D PETRI DISHES MARKET. 59
6.4             MICROFLUIDICS-BASED 3D CELL CULTURES.. 60
6.4.1              MICROFLUIDICS-BASED 3D CELL CULTURES WILL GROW AT THE HIGHEST RATE IN THE 3D CELL CULTURE MARKET
6.5             MAGNETIC & BIOPRINTED 3D CELL CULTURES
6.5.1              3D CELL CULTURE CAN BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION

7.... 3D CELL CULTURE MARKET, BY APPLICATION.. 64

7.1             INTRODUCTION
7.2             CANCER & STEM CELL RESEARCH
7.2.1              RISING PREVALENCE OF CANCER IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
7.3             DRUG DISCOVERY & TOXICOLOGY TESTING
7.3.1              INCREASING ADOPTION OF PERSONALIZED MEDICINES TO SUPPORT MARKET GROWTH
7.4             TISSUE ENGINEERING & REGENERATIVE MEDICINE
7.4.1              EUROPE IS EXPECTED TO REGISTER THE HIGHEST GROWTH IN THE TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET

8.... 3D CELL CULTURE MARKET, BY END USER

8.1             INTRODUCTION
8.2             PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1              PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF 3D CELL CULTURE
8.3             RESEARCH INSTITUTES
8.3.1              INCREASING GOVERNMENT FUNDING FOR RESEARCH & HIGH PREVALENCE OF CANCER ARE DRIVING MARKET GROWTH
8.4             COSMETICS INDUSTRY
8.4.1              FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
8.5             OTHER END USERS

9.... 3D CELL CULTURE MARKET, BY REGION

9.1             INTRODUCTION
9.2             NORTH AMERICA
9.2.1              US
9.2.1.1            THE US DOMINATES THE NORTH AMERICAN MARKET
9.2.2              CANADA
9.2.2.1            ADVANCEMENTS IN THE FIELD OF REGENERATIVE MEDICINE TO DRIVE MARKET GROWTH IN CANADA
9.3             EUROPE
9.3.1              GERMANY
9.3.1.1            INCREASING INVESTMENTS BY VARIOUS KEY PLAYERS AND GROWING FUNDING FROM GOVERNMENT ORGANIZATIONS TO DRIVE THE MARKET
9.3.2              UK
9.3.2.1            GROWTH IN THE LIFE SCIENCES INDUSTRY TO DRIVE MARKET GROWTH IN THE UK
9.3.3              FRANCE
9.3.3.1            GROWTH IN THE BIOTECHNOLOGY INDUSTRY TO DRIVE MARKET GROWTH IN FRANCE
9.3.4              ROE

9.4             ASIA PACIFIC
9.4.1              JAPAN
9.4.1.1            JAPAN TO DOMINATE THE ASIA PACIFIC MARKET
9.4.2              CHINA
9.4.2.1            GOVERNMENT SUPPORT & STRATEGIC INITIATIVES BY KEY PLAYERS TO STRENGTHEN THE BIOTECHNOLOGY SECTOR IN CHINA
9.4.3              INDIA
9.4.3.1            GROWTH IN THE LIFE SCIENCES INDUSTRY TO SUPPORT MARKET GROWTH IN INDIA
9.4.4              ROAPAC
9.5             REST OF THE WORLD

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          MARKET SHARES ANALYSIS, 2018
10.3          COMPETITIVE LEADERSHIP MAPPING
10.3.1            VISIONARY LEADERS.. 117
10.3.2            DYNAMIC DIFFERENTIATORS
10.3.3            INNOVATORS
10.3.4            EMERGING COMPANIES
10.4          COMPETITIVE SITUATION AND TRENDS
10.4.1            PRODUCT LAUNCHES & UPGRADES
10.4.2            EXPANSIONS
10.4.3            ACQUISITIONS
10.4.4            PARTNERSHIPS, AGREEMENTS, ALLIANCES, AND COLLABORATIONS
10.4.5            OTHER STRATEGIES.. 120

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW)*
11.1          THERMO FISHER SCIENTIFIC
11.2          CORNING INCORPORATED
11.3          MERCK KGAA
11.4          LONZA GROUP
11.5          REPROCELL
11.6          3D BIOTEK LLC
11.7          EMULATE, INC.
11.8          CN BIO INNOVATIONS LIMITED
11.9          HAMILTON COMPANY
11.10        INSPHERO AG
11.11        KIRKSTALL, LTD.

11.12        MIMETAS BV
11.13        TISSUSE GMBH
11.14        SYNTHECON INCORPORATED
11.15        QGEL SA
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.16        OTHER KEY PLAYERS
11.16.1         GREINER BIO-ONE INTERNATIONAL GMBH
11.16.2         PROMOCELL GMBH
11.16.3         ADVANCED BIOMATRIX, INC.
11.16.4         HµREL CORPORATION
11.16.5         SYNVIVO, INC.
12.. APPENDIX

LIST OF TABLES

TABLE 1              GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
TABLE 2              PREVALENCE OF DIABETES, BY REGION, 2000 VS. 2030
TABLE 3              INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2040
TABLE 4              3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 5              SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY PRODUCT,
2017–2024 (USD MILLION)
TABLE 6              SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 7              NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8              EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 9              ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10            HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11            NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 12            EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 13            ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 14            SOLID SCAFFOLDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15            NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 16            EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17            ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 18            MICROPATTERNED SURFACES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19            NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 20            EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 21            ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 22            SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY PRODUCT,
2017–2024 (USD MILLION)
TABLE 23            SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 24            NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25            EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 26            ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 27            LOW ATTACHMENT PLATES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 28            NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 29            EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 30            ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 31            HANGING DROP PLATES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 32            NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 33            EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 34            ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 35            3D BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 36            NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 37            EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38            ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 39            3D PETRI DISHES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 40            NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 41            EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42            ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 43            MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 44            NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 45            EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46            ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 47            MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 48            NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 49            EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 50            ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51            3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 52            3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2017–2024 (USD MILLION)
TABLE 53            NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 54            EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 55            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 56            3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING,
BY REGION, 2017–2024 (USD MILLION)
TABLE 57            NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY
& TOXICOLOGY TESTING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 58            EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 59            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 60            3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2017–2024 (USD MILLION)
TABLE 61            NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING
& REGENERATIVE MEDICINE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62            EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 63            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 64            3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65            3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 66            NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 67            EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 68            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 69            3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION,
2017–2024 (USD MILLION)
TABLE 70            NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 71            EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 72            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 73            3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY REGION,
2017–2024 (USD MILLION)
TABLE 74            NORTH AMERICA: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 75            EUROPE: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 76            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 77            3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION,
2017–2024 (USD MILLION)
TABLE 78            NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 79            EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 80            ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 81            3D CELL CULTURE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 82            NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 83            NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT,
2017–2024 (USD MILLION)
TABLE 84            NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85            NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 86            NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 87            NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 88            US: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 89            US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 90            US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 91            US: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 92            US: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 93            CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 94            CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 95            CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 96            CANADA: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 97            CANADA: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 98            EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 99            EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 100          EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 101          EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 102          EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 103          EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 104          GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 105          GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 106          GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 107          GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 108          GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 109          UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 110          UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 111          UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 112          UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 113          UK: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 114          FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 115          FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 116          FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 117          FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 118          FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 119          ROE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 120          ROE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 121          ROE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 122          ROE: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 123          ROE: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 124          APAC: 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 125          APAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 126          APAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 127          APAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 128          APAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 129          APAC: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 130          JAPAN: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 131          JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 132          JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 133          JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 134          JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 135          CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 136          CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 137          CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 138          CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 139          CHINA: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 140          INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 141          INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 142          INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 143          INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 144          INDIA: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 145          ROAPAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 146          ROAPAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 147          ROAPAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 148          ROAPAC: 3D CELL CULTURE MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 149          ROAPAC: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION).
TABLE 150          ROW: 3D CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 151          ROW: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 152          ROW: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 153          ROW: 3D CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 154          ROW: 3D CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 155          EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
TABLE 156          EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)

LIST OF FIGURES

FIGURE 1            RESEARCH METHODOLOGY STEPS: 3D CELL CULTURE MARKET
FIGURE 2            RESEARCH DESIGN
FIGURE 3            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 4            RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5            MARKET SIZE ESTIMATION: OVERALL 3D CELL CULTURE MARKET
FIGURE 6            DATA TRIANGULATION METHODOLOGY
FIGURE 7            3D CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 8            3D CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2014 (USD MILLION)
FIGURE 9            3D CELL CULTURE MARKET, BY END USER, 2019–2024 (USD MILLION)
FIGURE 10          GEOGRAPHICAL SNAPSHOT OF THE 3D CELL CULTURE MARKET
FIGURE 11          INCREASING FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS
A MAJOR FACTOR DRIVING THE ADOPTION OF 3D CELL CULTURE SOLUTIONS
FIGURE 12          HYDROGELS/ECM ANALOGS ARE EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 13          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR
THE LARGEST SHARE OF THE MARKET IN 2018
FIGURE 14          EUROPE IS EXPECTED TO GROW AT THE HIGHEST RATE DURING
THE FORECAST PERIOD
FIGURE 15          3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES
FIGURE 16          NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
FIGURE 17          EUROPE: 3D CELL CULTURE MARKET SNAPSHOT
FIGURE 18          KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES
FIGURE 19          MARKET EVOLUTION FRAMEWORK
FIGURE 20          3D CELL CULTURE MARKET SHARES ANALYSIS, BY KEY PLAYER, 2018
FIGURE 21          COMPETITIVE LEADERSHIP MAPPING
FIGURE 22          THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 23          CORNING INCORPORATED: COMPANY SNAPSHOT
FIGURE 24          MERCK KGAA: COMPANY SNAPSHOT
FIGURE 25          LONZA GROUP: COMPANY SNAPSHOT

当レポートのプレスリリースは発行されておりません。